Biden administration will select first 10 drugs for Medicare price negotiations by September
Publishing timestamp: 2023-01-11 21:30:23
Summary
The Health and Human Services Department will select 10 Medicare Part D drugs this year for price negotiations with manufacturers. The federal government will use Medicare spending data from June 2022 through May 2023 to guide its selection. Negotiations will end in August 2024 and the negotiated prices for those 10 Medicare Part D drugs will go into effect in January 2026. In the second phase, HHS will select another 15 Medicare Part D drugs to negotiate, with prices taking effect in 2027.
Sentiment: NEUTRAL
Tickers: JNJ, PFE, LLY, BMY, MRK, ABBV, AZN,
Keywords: eli lilly and co, politics, biotech and pharmaceuticals, abbvie inc, pandemics, business, coronavirus, pfizer inc, astrazeneca plc, business news, epidemics, biotechnology, health care industry, bristol-myers squibb co, breaking news: business, u.s. economy, disease outbreaks,